RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM)

Clinical trials for RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) explained in plain language.

Never miss a new study

Get alerted when new RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) trials appear

Sign up with your email to follow new studies for RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New cell therapy trial offers hope for patients with untreatable blood cancer

Disease control Not yet recruiting

This is an early safety study testing a new cell therapy called SL4903 for adults with multiple myeloma that has come back or stopped responding to standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to target the cancer, and infuse them b…

Matched conditions: RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM)

Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM)

Get alerted when new RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) trials appear

New cell therapy trial offers hope for patients with untreatable blood cancer